REG - BkofA Merrill Lynch Horizon Therapeutics - HORIZON THERAPEUTICS PLC_38.5 (b)_IE_BOFAS

AmgenAnnouncement

03/02/2023 12:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230203:nRSC8996Oa&default-theme=true

RNS Number : 8996O  Bank of America Merrill Lynch  03 February 2023

FORM 38.5(b)

 

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997,

TAKEOVER RULES, 2013

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT

RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNIZED INTERMEDIARY

STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

 

 1.  KEY INFORMATION

 Name of exempt principal trader             BofA Securities, Inc.
 Company dealt in                            HORIZON THERAPEUTICS PLC
 Class of relevant security to which the     Common - IE00BQPVQZ61

dealings being disclosed relate(Note 1)
 Date of dealing                             02/02/2023

BofA Securities, Inc.

 Company dealt in

HORIZON THERAPEUTICS PLC

 Class of relevant security to which the

dealings being disclosed relate(Note 1)

Common - IE00BQPVQZ61

 Date of dealing

02/02/2023

 

 2.  INTERESTS AND SHORT POSITIONS

 (a)  Interests and short positions (following dealing) in the class of relevant
      security

dealt in (Note 2)

 Class of relevant security: Common             IE00BQPVQZ61
                                                Long             Short
                                                Number   %       Number   %
 (1)  Relevant securities                       295,970  0.129%  29,044   0.013%
 (2)  Derivatives (other than options):         260,381  0.114%  277,184  0.121%
 (3)  Options and agreements to purchase/sell:  0        0%      1,700    0.001%
 Total                                          556,351  0.243%  307,928  0.135%

295,970

0.129%

29,044

0.013%

 (2)  Derivatives (other than options):

260,381

0.114%

277,184

0.121%

 (3)  Options and agreements to purchase/sell:

0

0%

1,700

0.001%

Total

556,351

0.243%

307,928

0.135%

 

 (b)  Interests and short positions in relevant securities of the company, other
      than the

class dealt in (Note 2)

 Class of relevant security:
                                                Long         Short
                                                Number  %    Number  %
 (1)  Relevant securities                       0       0%   0       0%
 (2)  Derivatives (other than options):         0       0%   0       0%
 (3)  Options and agreements to purchase/sell:  0       0%   0       0%
 Total                                          0       0%   0       0%

0

0%

0

0%

 (2)  Derivatives (other than options):

0

0%

0

0%

 (3)  Options and agreements to purchase/sell:

0

0%

0

0%

Total

0

0%

0

0%

 3.  DEALINGS (Note 3)

 (a)  Purchases and sales

 

 Purchase/sale  Number of relevant securities  Price per unit (Note 4)
 Purchase            2,500                     109.85 USD
 Purchase               100                    109.963 USD
 Purchase            1,280                     109.965 USD
 Purchase               900                    109.97 USD
 Purchase               120                    109.995 USD
 Purchase               100                    110 USD
 Purchase            2,500                     110.07 USD
 Purchase            2,500                     110.26 USD
 Purchase               341                    110.3 USD
 Purchase                 80                   109.65 USD
 Purchase                 80                   109.66 USD
 Purchase                  5                   109.686 USD
 Purchase                 63                   109.69 USD
 Purchase                 67                   109.7 USD
 Purchase                 80                   109.72 USD
 Purchase                 66                   109.73 USD
 Purchase               144                    109.74 USD
 Purchase               139                    109.75 USD
 Purchase                 12                   109.76 USD
 Purchase                 22                   109.771 USD
 Purchase                  8                   109.78 USD
 Purchase                 66                   109.79 USD
 Purchase                 46                   109.798 USD
 Purchase                 29                   109.799 USD
 Purchase               125                    109.8 USD
 Purchase                 27                   109.805 USD
 Purchase               118                    109.81 USD
 Purchase                 25                   109.814 USD
 Purchase                 23                   109.817 USD
 Purchase                 12                   109.82 USD
 Purchase                 28                   109.823 USD
 Purchase               123                    109.83 USD
 Purchase                 66                   109.84 USD
 Purchase                 66                   109.85 USD
 Purchase                 66                   109.86 USD
 Purchase                 80                   109.88 USD
 Purchase                 75                   109.94 USD
 Purchase               140                    110 USD
 Purchase                  8                   110.005 USD
 Purchase                 80                   110.01 USD
 Purchase                  6                   110.015 USD
 Purchase                  9                   110.06 USD
 Purchase                  8                   110.065 USD
 Purchase                 59                   110.08 USD
 Purchase               100                    110.085 USD
 Purchase                  2                   110.09 USD
 Purchase                 16                   110.1 USD
 Purchase               250                    110.11 USD
 Purchase               117                    110.12 USD
 Purchase                 16                   110.125 USD
 Purchase                 66                   110.13 USD
 Purchase                  2                   110.14 USD
 Purchase                 80                   110.24 USD

 

 Purchase/sale  Number of relevant securities  Price per unit (Note 4)
 Sale                     80                   109.65 USD
 Sale                     80                   109.66 USD
 Sale                      5                   109.686 USD
 Sale                     63                   109.69 USD
 Sale                     67                   109.7 USD
 Sale                     80                   109.72 USD
 Sale                     66                   109.73 USD
 Sale                   144                    109.74 USD
 Sale                   139                    109.75 USD
 Sale                     12                   109.76 USD
 Sale                     22                   109.771 USD
 Sale                      8                   109.78 USD
 Sale                     66                   109.79 USD
 Sale                     46                   109.798 USD
 Sale                     29                   109.799 USD
 Sale                   125                    109.8 USD
 Sale                     27                   109.805 USD
 Sale                   118                    109.81 USD
 Sale                     25                   109.814 USD
 Sale                     23                   109.817 USD
 Sale                     12                   109.82 USD
 Sale                     28                   109.823 USD
 Sale                   123                    109.83 USD
 Sale                     66                   109.84 USD
 Sale                     66                   109.85 USD
 Sale                     66                   109.86 USD
 Sale                     80                   109.88 USD
 Sale                     75                   109.94 USD
 Sale                   140                    110 USD
 Sale                      8                   110.005 USD
 Sale                     80                   110.01 USD
 Sale                      6                   110.015 USD
 Sale                      9                   110.06 USD
 Sale                      8                   110.065 USD
 Sale                     59                   110.08 USD
 Sale                   100                    110.085 USD
 Sale                      2                   110.09 USD
 Sale                     16                   110.1 USD
 Sale                   250                    110.11 USD
 Sale                   117                    110.12 USD
 Sale                     16                   110.125 USD
 Sale                     66                   110.13 USD
 Sale                      2                   110.14 USD
 Sale                     80                   110.24 USD
 Sale                2,000                     110.45 USD
 Sale                   230                    110.52 USD
 Sale                6,060                     109.79 USD

 

 (b)  Derivatives transactions (other than options transactions)

 Product name,  Nature of transaction       Number of relevant securities  Price per unit

e.g. CFD
(Note 5)                   (Note 6)
(Note 4)
 Swaps          Increasing a long position  2,000                          110.45 USD

 

 (c)  Options transactions in respect of existing relevant securities

 (i)  Writing, selling, purchasing or varying

 Product name, e.g. call option  Writing, selling, purchasing, varying etc.  Number of securities to which the option relates (Note 7)  Exercise price  Type, e.g. American, European etc  Expiry date  Option money paid/ received per unit (Note 4)
 N/A                             N/A                                         N/A                                                        N/A             N/A                                N/A          N/A

 

 (ii)  Exercising

 Product name,      Number of securities  Exercise price per

e.g. call option
unit (Note 4)
 N/A                N/A                   N/A

 

 (d)  Other dealings (including transactions in respect of new securities) (Note 3)

 Nature or transaction  Details  Price per unit
 (Note 7)
(if applicable) (Note 4)

 

 4.  OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 Full details of any agreement, arrangement or understanding between the person

disclosing and any other person relating to the voting rights of any relevant

securities under any option referred to on this form or relating to the voting
 rights

or future acquisition or disposal of any relevant securities to which any
 derivative

referred to on this form is referenced. If none, this should be stated.
 None

 

 Is a Supplemental Form 38.5(b) attached? (Note 8)  No

 

 Date of disclosure                            03/02/2023
 Contact name                                  Frank Lui
 Telephone number                              +44207 996 6418
 Name of offeree/offeror with which connected  AMGEN INC
 Nature of connection (Note 9)                 Advisor to - AMGEN INC

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ISEUOVRROWUURAR